Hamilton Thorne Graduating to Toronto Stock Exchange Main Board
06 sept. 2023 08h30 HE
|
Hamilton Thorne Ltd.
BEVERLY, Mass. and TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the...
GCC In-Vitro Fertilization (IVF) Market 2023: Infertility Solutions Drive Substantial Growth
05 sept. 2023 10h18 HE
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "GCC In-Vitro Fertilization Market By Technique (ICSI IVF, Non-ICSI/Traditional IVF), By Reagent, By Instruments, By Infertility, By Embryo, By...
In Vitro Fertilization (IVF) Market Size & Share to Surpass $1296.47 Mn by 2030 | Vantage Market Research
24 août 2023 06h39 HE
|
Vantage Market Research
WASHINGTON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, The Global In Vitro Fertilization Market is projected to reach a value of USD 1296.47 Million by 2030 and is...
Global In-Vitro Fertilization (IVF) Market 2023-2028: New AI and Robotic Technologies Transforming the IVF Market
22 août 2023 07h48 HE
|
Research and Markets
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global In-Vitro Fertilization (IVF) Market (2023-2028) by Instrument, Technology, End-User, Geography, Competitive Analysis and the Impact of Economic...
Hamilton Thorne Reports Revenue For The Quarter And Six Months Ended June 30, 2023
17 août 2023 08h45 HE
|
Hamilton Thorne Ltd.
BEVERLY, Mass. and TORONTO, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted...
GenEmbryomics Engages WallachBeth to Pursue Listing on a US National Stock Exchange
19 juil. 2023 08h00 HE
|
GenEmbryomics
MELBOURNE, Australia, July 19, 2023 (GLOBE NEWSWIRE) -- GenEmbryomics, a medical genetics company with world leading intellectual property, today announced that it has retained WallachBeth Capital...
ObsEva Recovers Full Worldwide Rights on Nolasiban
13 juil. 2023 01h00 HE
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – July 13, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's...
Infertility Treatment Devices and Equipment Global Market to 2030: Technological Advancements Bolsters Growth
06 juil. 2023 07h13 HE
|
Research and Markets
Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "Infertility Treatment Devices And Equipment Market Size, Share & Trends Analysis Report By Type, By End-use (Fertility Clinics, Hospitals &...
Centrifugation-free Sperm Separation Systems Market Poised for USD 200.0 Mn Revenue by 2031, Says Transparency Market Research
12 juin 2023 17h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 13, 2023 (GLOBE NEWSWIRE) -- The global centrifugation-free sperm separation systems market is projected to reach approximately USD 200.0 Mn by 2031 with...
In Vitro Fertilization Market to Hit US$ 40.6 Bn in 2032 | Grow CAGR by 7.8% (Y-O-Y)
22 mai 2023 04h56 HE
|
Market.Us
New York, May 22, 2023 (GLOBE NEWSWIRE) -- According to Market.us, The global In Vitro Fertilization Market size is expected to be worth around USD 40.6 Billion by 2032 from USD 19.5 Billion in...